Mendy Ter Avest

7PUBLICATIONS
3CO-AUTHORS
HaematologyEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2025
Model-Informed Precision Dosing of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Mendy Ter Avest, Saskia M C Langemeijer, Lambertus P W J van den Heuvel

|Nov 12, 2024
Prospective validation of initial eculizumab dosing in adults with atypical hemolytic uremic syndrome.

Mendy Ter Avest, Caroline Duineveld, Romy N Bouwmeester

|Mar 07, 2024
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan.

Mendy Ter Avest, Saskia M C Langemeijer, Nicole M A Blijlevens

|Nov 17, 2022
Dose optimalization of subcutaneous ravulizumab is predicted to yield significant savings and to improve patient friendliness.

Mendy Ter Avest, Saskia M C Langemeijer, Nicole M A Blijlevens

|Mar 03, 2022
Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective.

Mendy Ter Avest, Romy N Bouwmeester, Caroline Duineveld

Pageof 2